Aug 2026· Frontiers in Pain Research· Vol 7· 0 citations· 233 references
Medicine
TL;DR
This work reviews implanted neuromodulation approaches, highlighting the recurring patterns that have shaped the evolution of pain neuromodulation and outlining priorities for the field, including more rigorous trial design, standardized reporting of stimulation parameters and outcomes, and clearer indication-specific evidence to support clinical translation.
Abstract
Electromagnetic neuromodulation is increasingly used as an adjunct or alternative to pharmacologic therapy for pain, with several approaches cleared for select indications and many others under active investigation. We review implanted neuromodulation approaches (intracranial and spinal), vagal neuromodulation, noninvasive central/cranial neuromodulation, peripheral neuromodulation, and hybrid/multimodal approaches, with a primary focus on chronic pain management and brief coverage of selected acute-use indications (e.g., primary headache disorders) where relevant. Beyond summarizing individual modalities, we highlight the recurring patterns that have shaped the evolution of pain neuromodulation. For each modality, we summarize putative mechanism of action, typical stimulation paradigms, and key strengths and limitations of the clinical evidence, emphasizing sources of heterogeneity that complicate cross-study comparison and translation. We conclude by outlining priorities for the field, including more rigorous trial design, standardized reporting of stimulation parameters and outcomes, and clearer indication-specific evidence to support clinical translation.
The available literature supports a biologically plausible and clinically promising role for neuromodulation in selected neuromuscular pain phenotypes, particularly where neuropathic mechanisms predominate, but the evidence base remains fragmented, with limited disease specific trials and substantial heterogeneity in p...
Mert Sabıroğlu, William J. D. Arnold· Current Pain and Headache Re...· 0 citations
Future progress in SCS will likely depend on artificial intelligence, remote monitoring, biomarker-guided programming, and integration with multidisciplinary chronic pain care.
Nafay Abdul, Milan Patel, Rohit Aiyer et al.· Journal of Clinical Medicine· 0 citations
An evidence-informed clinical roadmap to support decision-making for non-invasive neuromodulation in NeP is developed and refinement of the treatment sequence and removal of transcutaneous auricular vagus nerve stimulation is removed from the roadmap.
R. J. Duarte-Moreira, Tiago da Silva Lopes, A. M. Fernandes et al.· Brain Imaging and Stimulatio...· 0 citations
ABSTRACT Introduction Chronic migraine (CM) refractory to conventional pharmacotherapy (r-CM) remains a debilitating neurological condition with limited therapeutic options. High-frequency spinal cord stimulation at 10 kilohertz (HF-SCS) has recently emerged as a distinct neuromodulatory paradigm for this patient popul...
Paolo Martelletti, Claudio Tana· Expert Review of Neurotherap...· 0 citations
Post-craniotomy headache (PCH) is a common complication following neurosurgery, yet there remains limited consensus regarding the mechanism, classification, and optimal management. This review summarizes the current literature and highlights recent trends in procedural therapies. PCH occurs in approximately 60–70% of p...
S. Friedman, Arathi Nandyala· Current Pain and Headache Re...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.